Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Sc Hui

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Infection|September 3, 2022
Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitisChristopher Kc Lai, Grace Cy Lui, Yuchen Wei, et al.
Eclinicalmedicine|November 8, 2021
Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protectionEric Hy Lau, David Sc Hui, Owen Ty Tsang, et al.
The Journal of Infection|July 28, 2021
Comparison of self-collected mouth gargle with deep-throat saliva samples for the diagnosis of COVID-19: Mouth gargle for diagnosis of COVID-19Christopher Kc Lai, Grace Cy Lui, Zigui Chen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 6, 2022
SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022Samuel Ms Cheng, Chris Ka Pun Mok, Karl Ck Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Nature Communications|August 23, 2025
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adultsCarolyn A Cohen, Ludivine Grzelak, Susan S Chiu, et al.
Gut Microbes|October 6, 2022
Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patientsQi Su, Qin Liu, Lin Zhang, et al.
Gut|February 10, 2022
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse eventsSiew C Ng, Ye Peng, Lin Zhang, et al.
Nature Communications|December 21, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation studyZihao Guo, Yuchen Wei, Guozhang Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infectionCarolyn A Cohen, Athena Py Li, Asmaa Hachim, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Infection|September 3, 2022
Remdesivir reduced upper respiratory tract SARS-CoV-2 viral RNA concentration in COVID-19 patients who developed pneumonitisChristopher Kc Lai, Grace Cy Lui, Yuchen Wei, et al.
Eclinicalmedicine|November 8, 2021
Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protectionEric Hy Lau, David Sc Hui, Owen Ty Tsang, et al.
The Journal of Infection|July 28, 2021
Comparison of self-collected mouth gargle with deep-throat saliva samples for the diagnosis of COVID-19: Mouth gargle for diagnosis of COVID-19Christopher Kc Lai, Grace Cy Lui, Zigui Chen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 6, 2022
SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022Samuel Ms Cheng, Chris Ka Pun Mok, Karl Ck Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Nature Communications|August 23, 2025
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adultsCarolyn A Cohen, Ludivine Grzelak, Susan S Chiu, et al.
Gut Microbes|October 6, 2022
Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patientsQi Su, Qin Liu, Lin Zhang, et al.
Gut|February 10, 2022
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse eventsSiew C Ng, Ye Peng, Lin Zhang, et al.
Nature Communications|December 21, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation studyZihao Guo, Yuchen Wei, Guozhang Lin, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infectionCarolyn A Cohen, Athena Py Li, Asmaa Hachim, et al.
Pageof 3